Role for sphingosine kinase 1 in colon carcinogenesis

FASEB Journal

Volumn 23, Issue 2, 2009, Pages 405-414

  Kawamori, Toshihiko ^a   Kaneshiro, Tatsuya ^a   Okumura, Masae ^a   Maalouf, Samer ^a   Uflacker, Andre ^a   Bielawski, Jacek ^a   Hannun, Yusuf A ^a   Obeid, Lina M ^a  

^a MEDICAL UNIVERSITY OF SOUTH CAROLINA   (United States)

Author keywords

Apoptosis; Azoxymethane; Cell proliferation; Dextran sodium sulfate; Inflammation

Indexed keywords

AZOXYMETHANE; SPHINGOSINE KINASE 1;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CANCER GROWTH; CHEMOPROPHYLAXIS; COLON CARCINOGENESIS; COLON MUCOSA; COLORECTAL ADENOMA; CONTROLLED STUDY; ENZYME BLOOD LEVEL; HUMAN; HUMAN CELL; IMMUNOHISTOCHEMISTRY; METASTASIS; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN FUNCTION; PROTEIN PHOSPHORYLATION;

ANIMALS; AZOXYMETHANE; CELL TRANSFORMATION, NEOPLASTIC; COLONIC NEOPLASMS; CYCLOOXYGENASE 2; DEXTRAN SULFATE; GENE EXPRESSION REGULATION, ENZYMOLOGIC; GENE EXPRESSION REGULATION, NEOPLASTIC; HUMANS; INFLAMMATION; LYSOPHOSPHOLIPIDS; MICE; MICE, KNOCKOUT; PHOSPHOTRANSFERASES (ALCOHOL GROUP ACCEPTOR); SPHINGOSINE;

MURINAE; MUS;

EID: 59649086217     PISSN: 08926638     EISSN: 15306860     Source Type: Journal    
DOI: 10.1096/fj.08-117572     Document Type: Article

References (27)

1. Jemal, A., Siegel, R., Ward, E., Murray, T., Xu,J., and Thun, M.J. (2007) Cancer statistics, 2007. CA Cancer J. Clin. 57, 43-66
2. Ogretmen, B., and Hannun, Y. A. (2004) Biologically active sphingolipids in cancer pathogenesis and treatment. Nat. Rev. Cancer 4, 604-616
3. Liu, H., Chakravarty, D., Maceyka, M., Milstien, S., and Spiegel, S. (2002) Sphingosine kinases: a novel family of lipid kinases. Prog. Nucleic Acids Res. Mol. Biol. 71, 493-511
4. Spiegel, S., and Milstien, S. (2000) Sphingosine-1-phosphate: signaling inside and out. FEBS Lett. 476, 55-57
5. Pyne, S., and Pyne, N. J. (2000) Sphingosine 1-phosphate signalling in mammalian cells. Biochem. J. 349, 385-402
6. Xia, P., Gamble, J. R., Wang, L., Pitson, S. M., Moretti, P. A., Wattenberg, B. W., D'Andrea, R. J., and Vadas, M. A. (2000) An oncogenic role of sphingosine kinase. Curr. Biol. l0, 1527-1530
7. Kawamori, T., Rao, C. V., Seibert, K., and Reddy, B. S. (1998) Chemopreventive activity of celecoxib, a specific cyclooxygenase-2 inhibitor, against colon carcinogenesis. Cancer Res. 58, 409-412
8. Nakatsugi, S., Fukutake, M., Takahashi, M., Fukuda, K., Isoi, T., Taniguchi, Y., Sugimura, T., and Wakabayashi, K. (1997) Suppression of intestinal polyp development by nimesulide, a selective cyclooxygenase-2 inhibitor, in Min mice. Jpn. J. Cancer Res. 88, 1117-1120
9. Steinbach, G., Lynch, P. M., Phillips, R. K., Wallace, M. H., Hawk, E., Gordon, G. B., Wakabayashi, N., Saunders, B., Shen, Y., Fujimura, T., Su, L. K., and Levin, B. (2000) The effect of celecoxib, a cyclooxygenase-2 inhibitor, in familial adenomatous polyposis. N. Engl. J. Med. 342, 1946-1952
10. Kawamori, T., Uchiya, N., Sugimura, T., and Wakabayashi, K. (2003) Enhancement of colon carcinogenesis by prostaglandin E2 administration. Carcinogenesis 24, 985-990
11. Hansen-Petrik, M. B., McEntee, M. F.,Jull, B., Shi, H., Zemel, M. B., and Whelan, J. (2002) Prostaglandin E(2) protects intestinal tumors from nonsteroidal anti-inflammatory drug-induced regression in Apc(Min/+) mice. Cancer Res. 62, 403-408
12. Pettus, B. J., Bielawski, J., Porcelli, A. M., Reames, D. L., Johnson, K. R., Morrow, J., Chalfant, C. E., Obeid, L. M., and Hannun, Y. A. (2003) The sphingosine kinase 1/sphingosine-1-phosphate pathway mediates COX-2 induction and PGE2 production in response to TNF-alpha. FASEB J. 17, 1411-1421
13. Kawamori, T., Osta, W., Johnson, K. R., Pettus, B. J., Bielawski, J., Tanaka, T., Wargovich, M. J., Reddy, B. S., Hannun, Y. A., Obeid, L. M., and Zhou, D. (2006) Sphingosine kinase 1 is up-regulated in colon carcinogenesis. FASEB J. 20, 386-388
14. Billich, A., Bornancin, F., Mechtcheriakova, D., Natt, F., Huesken, D., and Baumruker, T. (2005) Basal and induced sphingosine kinase 1 activity in A549 carcinoma cells: function in cell survival and IL-1beta and TNF-alpha induced production of inflammatory mediators. Cell. Signal. l7, 1203-1217
15. Pettus, B. J., Kitatani, K., Chalfant, C. E., Taha, T. A., Kawamori, T., Bielawski, J., Obeid, L. M., and Hannun, Y. A. (2005) The coordination of prostaglandin E2 production by sphingosine-1- phosphate and ceramide-1- phosphate. Mol. Pharmacol. 68, 330-335
16. Kohno, M., Momoi, M., Oo, M. L., Paik, J. H., Lee, Y. M., Venkataraman, K., Ai, Y., Ristimaki, A. P., Fyrst, H., Sano, H., Rosenberg, D., Saba, J. D., Proia, R. L., and Hla, T. (2006) Intracellular role for sphingosine kinase 1 in intestinal adenoma cell proliferation. Mol. Cell. Biol. 26, 7211-7223
17. Okayasu, I., Hatakeyama, S., Yamada, M., Ohkusa, T., Inagaki, Y., and Nakaya, R. (1990) A novel method in the induction of reliable experimental acute and chronic ulcerative colitis in mice. Gastroenterology 98, 694-702
18. Tanaka, T., Kohno, H., Suzuki, R., Yamada, Y., Sugie, S., and Mori, H. (2003) A novel inflammation-related mouse colon carcinogenesis model induced by azoxymethane and dextran sodium sulfate. Cancer Sci. 94, 965-973
19. Johnson, K. R., Becker, K. P., Facchinetti, M. M., Hannun, Y. A., and Obeid, L. M. (2002) PKC-dependent activation of sphingosine kinase 1 and translocation to the plasma membrane. Extracellular release of sphingosine-1-phosphate induced by phorbol 12-myristate 13-acetate (PMA). J. Biol. Chem. 277, 35257-35262
20. Allende, M. L., Sasaki, T., Kawai, H., Olivera, A., Mi, Y., van Echten-Deckert, G., Hajdu, R., Rosenbach, M., Keohane, C. A., Mandala, S., Spiegel, S., and Proia, R. L. (2004) Mice deficient in sphingosine kinase 1 are rendered lymphopenic by FTY720. J. Biol. Chem. 279, 52487-52492
21. Zemann, B., Kinzel, B., Muller, M., Reuschel, R., Mechtcheriakova, D., Urtz, N., Bornancin, F., Baumruker, T., and Billich, A. (2006) Sphingosine kinase type 2 is essential for lymphopenia induced by the immunomodulatory drug FTY720. Blood l07, 1454-1458
22. Bird, R. P. (1987) Observation and quantification of aberrant crypts in the murine colon treated with a colon carcinogen: preliminary findings. Cancer Lett. 37, 147-151
23. Krutovskikh, V. A., and Turusov, V. S. (1994) Tumours of the intestines. IARC Sci. Publ. 195-221
24. Muller, P. Y., Janovjak, H., Miserez, A. R., and Dobbie, Z. (2002) Processing of gene expression data generated by quantitative real-time RT-PCR. Bio Techniques 32, 1372-1379
25. Murate, T., Banno, Y., K, T. K., Watanabe, K., Mori, N., Wada, A., Igarashi, Y., Takagi, A., Kojima, T., Asano, H., Akao, Y., Yoshida, S., Saito, H., and Nozawa, Y. (2001) Cell type-specific localization of sphingosine kinase 1a in human tissues. J. Histochem. Cytochem. 49, 845-855
26. Fukuda, Y., Kihara, A., and Igarashi, Y. (2003) Distribution of sphingosine kinase activity in mouse tissues: contribution of SPHK1. Biochem. Biophys. Res. Commun. 309, 155-160
27. French, K. J., Schrecengost, R. S., Lee, B. D., Zhuang, Y., Smith, S. N., Eberly,J. L.,Yun,J. K., and Smith, C. D. (2003) Discovery and evaluation of inhibitors of human sphingosine kinase. Cancer Res. 63, 5962-5969